Cargando…

The Minimum Effective Analgesic Volume of 0.5% Bupivacaine for Ultrasound-Guided Anterior Suprascapular Nerve Block

Objective The interscalene brachial plexus block (ISBB) constitutes the gold standard for analgesia after shoulder procedures. Ipsilateral phrenic nerve block remains the most common adverse effect after ISBB. Alternative nerve blocks are performed in shoulder surgery in order to prevent hemi-diaphr...

Descripción completa

Detalles Bibliográficos
Autores principales: Coşarcan, Sami Kaan, Doğan, Alper T, Koyuncu, Özgür, Gurkan, Yavuz, Erçelen, Ömür
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741702/
https://www.ncbi.nlm.nih.gov/pubmed/36514616
http://dx.doi.org/10.7759/cureus.31350
_version_ 1784848375631314944
author Coşarcan, Sami Kaan
Doğan, Alper T
Koyuncu, Özgür
Gurkan, Yavuz
Erçelen, Ömür
author_facet Coşarcan, Sami Kaan
Doğan, Alper T
Koyuncu, Özgür
Gurkan, Yavuz
Erçelen, Ömür
author_sort Coşarcan, Sami Kaan
collection PubMed
description Objective The interscalene brachial plexus block (ISBB) constitutes the gold standard for analgesia after shoulder procedures. Ipsilateral phrenic nerve block remains the most common adverse effect after ISBB. Alternative nerve blocks are performed in shoulder surgery in order to prevent hemi-diaphragmatic paralysis (HDP). The purpose of the present study was to investigate the minimum effective local anesthetic volume of 0.5% bupivacaine for postoperative analgesia with an anterior suprascapular nerve block (ASSB). The secondary aim was to investigate diaphragm functions with the local anesthetic doses used while conducting effective volume research. Method This prospective observational study was conducted at the American Hospital of Istanbul, Turkey, from March to July 2022. The initial injected volume of 0.5% bupivacaine was 10 ml. Our clinical experience indicates that this yields a complete sensory block of the anterior suprascapular nerve. In accordance with the up-and-down method, the volume of 0.5% bupivacaine used for a particular patient was determined by the outcome of the preceding block, which represented block success. In case of effective ASSB being achieved, the volume of 0.5% bupivacaine to be administered to the next patient was lowered by 1 ml. In case of block failure, however, the volume of 0.5% bupivacaine to be applied in the subsequent case was increased by 1 ml. Ipsilateral hemi-diaphragmatic movement measurements were taken before (baseline) and 30 minutes after the block. General anesthesia was induced 60 minutes after the completion of the block performance by means of a standardized protocol. Results Sixty-seven patients were included in the study. The ED50 and ED95 calculated for anterior suprascapular nerve block using probit transformation and logistic regression analysis were 2.646 (95% CI, 0.877-2.890) and 3.043 ml (95% CI, 2.771-4.065), respectively. When complete paralysis was defined as 75% or above, partial paralysis as 25-50%, and no paralysis as 25% or less, volumes of 6 ml or lower appeared to cause no paralysis for the anterior suprascapular nerve block. Conclusion We, therefore, recommend using a volume of 6 ml or less in order to achieve diaphragm-sparing features for anterior suprascapular nerve blocks.
format Online
Article
Text
id pubmed-9741702
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-97417022022-12-12 The Minimum Effective Analgesic Volume of 0.5% Bupivacaine for Ultrasound-Guided Anterior Suprascapular Nerve Block Coşarcan, Sami Kaan Doğan, Alper T Koyuncu, Özgür Gurkan, Yavuz Erçelen, Ömür Cureus Anesthesiology Objective The interscalene brachial plexus block (ISBB) constitutes the gold standard for analgesia after shoulder procedures. Ipsilateral phrenic nerve block remains the most common adverse effect after ISBB. Alternative nerve blocks are performed in shoulder surgery in order to prevent hemi-diaphragmatic paralysis (HDP). The purpose of the present study was to investigate the minimum effective local anesthetic volume of 0.5% bupivacaine for postoperative analgesia with an anterior suprascapular nerve block (ASSB). The secondary aim was to investigate diaphragm functions with the local anesthetic doses used while conducting effective volume research. Method This prospective observational study was conducted at the American Hospital of Istanbul, Turkey, from March to July 2022. The initial injected volume of 0.5% bupivacaine was 10 ml. Our clinical experience indicates that this yields a complete sensory block of the anterior suprascapular nerve. In accordance with the up-and-down method, the volume of 0.5% bupivacaine used for a particular patient was determined by the outcome of the preceding block, which represented block success. In case of effective ASSB being achieved, the volume of 0.5% bupivacaine to be administered to the next patient was lowered by 1 ml. In case of block failure, however, the volume of 0.5% bupivacaine to be applied in the subsequent case was increased by 1 ml. Ipsilateral hemi-diaphragmatic movement measurements were taken before (baseline) and 30 minutes after the block. General anesthesia was induced 60 minutes after the completion of the block performance by means of a standardized protocol. Results Sixty-seven patients were included in the study. The ED50 and ED95 calculated for anterior suprascapular nerve block using probit transformation and logistic regression analysis were 2.646 (95% CI, 0.877-2.890) and 3.043 ml (95% CI, 2.771-4.065), respectively. When complete paralysis was defined as 75% or above, partial paralysis as 25-50%, and no paralysis as 25% or less, volumes of 6 ml or lower appeared to cause no paralysis for the anterior suprascapular nerve block. Conclusion We, therefore, recommend using a volume of 6 ml or less in order to achieve diaphragm-sparing features for anterior suprascapular nerve blocks. Cureus 2022-11-10 /pmc/articles/PMC9741702/ /pubmed/36514616 http://dx.doi.org/10.7759/cureus.31350 Text en Copyright © 2022, Coşarcan et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Anesthesiology
Coşarcan, Sami Kaan
Doğan, Alper T
Koyuncu, Özgür
Gurkan, Yavuz
Erçelen, Ömür
The Minimum Effective Analgesic Volume of 0.5% Bupivacaine for Ultrasound-Guided Anterior Suprascapular Nerve Block
title The Minimum Effective Analgesic Volume of 0.5% Bupivacaine for Ultrasound-Guided Anterior Suprascapular Nerve Block
title_full The Minimum Effective Analgesic Volume of 0.5% Bupivacaine for Ultrasound-Guided Anterior Suprascapular Nerve Block
title_fullStr The Minimum Effective Analgesic Volume of 0.5% Bupivacaine for Ultrasound-Guided Anterior Suprascapular Nerve Block
title_full_unstemmed The Minimum Effective Analgesic Volume of 0.5% Bupivacaine for Ultrasound-Guided Anterior Suprascapular Nerve Block
title_short The Minimum Effective Analgesic Volume of 0.5% Bupivacaine for Ultrasound-Guided Anterior Suprascapular Nerve Block
title_sort minimum effective analgesic volume of 0.5% bupivacaine for ultrasound-guided anterior suprascapular nerve block
topic Anesthesiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741702/
https://www.ncbi.nlm.nih.gov/pubmed/36514616
http://dx.doi.org/10.7759/cureus.31350
work_keys_str_mv AT cosarcansamikaan theminimumeffectiveanalgesicvolumeof05bupivacaineforultrasoundguidedanteriorsuprascapularnerveblock
AT doganalpert theminimumeffectiveanalgesicvolumeof05bupivacaineforultrasoundguidedanteriorsuprascapularnerveblock
AT koyuncuozgur theminimumeffectiveanalgesicvolumeof05bupivacaineforultrasoundguidedanteriorsuprascapularnerveblock
AT gurkanyavuz theminimumeffectiveanalgesicvolumeof05bupivacaineforultrasoundguidedanteriorsuprascapularnerveblock
AT ercelenomur theminimumeffectiveanalgesicvolumeof05bupivacaineforultrasoundguidedanteriorsuprascapularnerveblock
AT cosarcansamikaan minimumeffectiveanalgesicvolumeof05bupivacaineforultrasoundguidedanteriorsuprascapularnerveblock
AT doganalpert minimumeffectiveanalgesicvolumeof05bupivacaineforultrasoundguidedanteriorsuprascapularnerveblock
AT koyuncuozgur minimumeffectiveanalgesicvolumeof05bupivacaineforultrasoundguidedanteriorsuprascapularnerveblock
AT gurkanyavuz minimumeffectiveanalgesicvolumeof05bupivacaineforultrasoundguidedanteriorsuprascapularnerveblock
AT ercelenomur minimumeffectiveanalgesicvolumeof05bupivacaineforultrasoundguidedanteriorsuprascapularnerveblock